These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23588624)

  • 1. Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance?
    LaFemina J; Chou JF; Gönen M; Rocha FG; Correa-Gallego C; Kingham TP; Fong Y; D'Angelica MI; Jarnagin WR; DeMatteo RP; Allen PJ
    J Gastrointest Surg; 2013 Jun; 17(6):1092-7. PubMed ID: 23588624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the involvement of the hepatic artery lymph node a poor prognostic factor in pancreatic adenocarcinoma?
    Rodrigues V; Dopazo C; Pando E; Blanco L; Caralt M; Gómez-Gavara C; Bilbao I; Salcedo MT; Balsells J; Charco R
    Cir Esp (Engl Ed); 2020 Apr; 98(4):204-211. PubMed ID: 31839175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery.
    Philips P; Dunki-Jacobs E; Agle SC; Scoggins C; McMasters KM; Martin RC
    HPB (Oxford); 2014 Dec; 16(12):1051-5. PubMed ID: 25123504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy.
    Perlmutter BC; Hossain MS; Naples R; Tu C; Vilchez V; McMichael J; Tullio K; Simon R; Walsh RM; Augustin T
    J Surg Oncol; 2021 Feb; 123(2):399-406. PubMed ID: 33159317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic artery lymph node relevance in periampullary tumors: A retrospective analysis of survival outcomes.
    Conde D; Rey C; Pardo M; Recaman A; Sabogal Olarte JC
    Front Surg; 2022; 9():963855. PubMed ID: 36561573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
    Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
    J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
    Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
    Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
    Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
    Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
    World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma.
    Sergeant G; Ectors N; Fieuws S; Aerts R; Topal B
    Ann Surg Oncol; 2009 Nov; 16(11):3070-9. PubMed ID: 19649555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
    Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
    Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.
    John BJ; Naik P; Ironside A; Davidson BR; Fusai G; Gillmore R; Watkins J; Rahman SH
    HPB (Oxford); 2013 Sep; 15(9):674-80. PubMed ID: 23458477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome.
    Baldwin S; Kukar M; Gabriel E; Attwood K; Wilkinson N; Hochwald SN; Kuvshinoff B
    HPB (Oxford); 2016 Jun; 18(6):523-8. PubMed ID: 27317957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
    Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
    Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
    Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
    HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.
    Masuda T; Dann AM; Elliott IA; Baba H; Kim S; Sedarat A; Muthusamy VR; Girgis MD; Joe Hines O; Reber HA; Donahue TR
    J Gastrointest Surg; 2018 Feb; 22(2):295-302. PubMed ID: 29043580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.